Company profile
ICU Medical, Inc.
NASDAQ: ICUI · Healthcare · Medical - Instruments & Supplies
#108 of 1,418 Healthcare companies by revenue34th-percentile growth
EA Score
78B+FH 79DQ 87GM 46SS 94
v0.1 · 65/100 weight · provisional
↑ disclosure history, listing tenure · ↓ revenue growth (YoY), 3-yr revenue growth
Methodology →Revenue TTM
$2.2B
Rev growth YoY (TTM)
-10.9%
Net income (FY)
$732.0k
Employees
13,000
as of 2026-08-07
Market cap
$4.2B
as of 2026-08-07
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$2.2B$2.2B2025
Net income$732.0k$732.0k2025
Operating income$42.8M$42.8M2025
Total assets$4.1B$4.1B2025
Equity$2.1B$2.1B2025
Revenue trend
FY2020 – FY2025 · USD
FY20
FY20
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Equipment revenue71%
Software revenue30%
Other deferred revenue1%
Government Grant Revenue-2%
By geography
UNITED STATES61%
EMEA18%
Asia Pacific10%
Other foreign countries10%
The read
What is ICU Medical, Inc.’s revenue?
ICU Medical, Inc. booked $2.2B in FY2025 revenue, contracting 6.3% year over year — slower than 66% of Healthcare companies we track, at a 0.0% net margin.
Peers · Healthcare
Exelixis, Inc.89ANatera, Inc.75B+Enovis Corporation66BConcentra Group Holdings Parent, Inc.68BPrivia Health Group, Inc.68BRadNet, Inc.73BNeighbors
Orange →Key facts
CEOVivek Jain
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersSan Clemente, CA
ExchangeNASDAQ: ICUI
Employees13,000
IPO date1992-03-31
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.